LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia

Lenalidomide shows promise in chronic lymphocytic leukemia (CLL), mediating its anti-leukemic effect through direct cytotoxicity, modulation of the tumor microenvironment, and correction of functio...